Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-697-5 | CAS number: -
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- The test was conducted by means of Read Across approach. Further information was attached at section 13
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 975
- Report date:
- 1975
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- - Principle of test: single oral administration
- Observation period: 7 days
- Parameters analysed / observed: mortality - GLP compliance:
- no
- Remarks:
- Pre 1981
Test material
- Reference substance name:
- Similar Substance 01 - ABr165:1
- IUPAC Name:
- Similar Substance 01 - ABr165:1
- Test material form:
- not specified
Constituent 1
Test animals
- Species:
- rat
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- - Concentration in vehicle: 3 to 35 % suspension in 0.5 % CMC solution.
Results and discussion
Effect levels
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality observed.
- Clinical signs:
- other: Dyspnea, feces blackened, some animals showed diarrhea and slight apathy.
- Gross pathology:
- No abnormalities detected.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP Criteria not met
- Conclusions:
- LD50 > 10000 mg/kg b.w.
- Executive summary:
Rats were exposed to a single oral dose of the test item, which followed a period of observation of 7 days.
No mortality was recorded; no significant clinical signs or organ abnormalities were recorded.
Conclusion
LD50 > 10000 mg/kg b.w.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
